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Autism is a genetically complex neurodevelopmental syndrome in which language deﬁcits are a core feature. We describe results from
two complimentary approaches used to identify risk variants on chromosome 7 that likely contribute to the etiology of autism. A
two-stage association study tested 2758 SNPs across a 10 Mb 7q35 language-related autism QTL in AGRE (Autism Genetic Resource
Exchange) trios1,2 and found signiﬁcant association with Contactin Associated Protein-Like 2 (CNTNAP2), a strong a priori candidate.
Male-only containing families were identiﬁed as primarily responsible for this association signal, consistent with the strongmale affection
bias in ASD and other language-based disorders. Gene-expression analyses in developing human brain further identiﬁed CNTNAP2 as en-
riched in circuits important for language development. Together, these results provide convergent evidence for involvement ofCNTNAP2,
a Neurexin family member, in autism, and demonstrate a connection between genetic risk for autism and speciﬁc brain structures.Introduction
Autism (MIM 209850) is a common and heterogeneous
neurodevelopmental disorder, characterized by language
impairments, social and communicative deﬁcits, and re-
petitive behaviors.3 Although heritability estimates for
autism spectrum disorder (ASD) range between 70% and
90%,4 the variable phenotype and complex genetic archi-
tecture has challenged efforts to identify ASD-susceptibil-
ity genes. Thus far, regions on chromosomes 7q and 17q
have the strongest statistical support for an involvement
in the etiology of ASD from independent studies, but risk
alleles within these regions remain to be unambiguously
identiﬁed.1,5–10 Recent studies have also demonstrated
a role of submicroscopic deletions and duplications in
ASD etiology, which appears to have a greater importance
in simplex than multiplex autism.11,12
We have undertaken a comprehensive approach to iden-
tify speciﬁc genes contributing both to the qualitative di-
agnosis of ASD as well as quantitative components of the
phenotype.1,2,13 Language problems are one of the essen-
tial features of autism,14 and substantial language delay,
deﬁned as a lag in the age of the ﬁrst spoken word or the
ﬁrst spoken phrase, is seen in approximately half of chil-
dren with autism and is observed in their unaffected sib-
lings at increased rates.15 In the only quantitative linkage
scan for a language endophenotype in autism, we identi-
ﬁed a quantitative trait locus (QTL) related to language de-
lay (‘‘age at ﬁrst word;’’ WORD) across a 10 cM region at
7q35.1 Fine mapping of this region in 291 families showed
evidence of suggestive linkage to the qualitative diagnosis150 The American Journal of Human Genetics 82, 150–159, Januaryof autism16 and provided support for the 7q35 language
QTL,2 but also revealed substantial genetic heterogeneity.2
Here we present results from a high-density SNP-based
study of the 15 Mb 7q34–36 region encompassing the
10 Mb 7q35 QTL.1,2 Polymorphisms across this interval, at
an average intermarker distance of 5.6 Kb, were tested for
association to age at ﬁrst word. In Stage 1, 172 parent-child
trios from the AGRE resource were genotyped on 2758
SNPs across the 15 Mb region containing approximately
200 known genes.17,18 These analyses identiﬁed four genes
for follow up (Figure 1), including Contactin Associated Pro-
tein-like 2 (CNTNAP2), a member of the Neurexin family.19
Two separate lines of evidence made CNTNAP2 a strong
a priori candidate within this region. First, neurexins are
known to interact functionally with genes previously
identiﬁed as mutated in ASD.20,21 Second, mutations in
CNTNAP2 itself were recently identiﬁed in an Amish fam-
ily with seizures, language regression, and pervasive devel-
opmental disorder.22 In Stage 2, we tested 304 independent
parent-child trios for association to the four genes high-
lighted in Stage 1; these analyses conﬁrmed association
between age at ﬁrst word and CNTNAP2.
In independent but complementary work, we isolated
CNTNAP2 in whole-transcriptomemicroarray experiments
designed to characterize gene expression in language-
related brain structures in the developing human cortex.
Subsequent in situ hybridizations in separate human fetal
brains determined that a CNTNAP2 transcript was strik-
ingly restricted to developing frontotemporal-subcortical
circuits known to be critical for human executive function.
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attention, an essential precursor to verbal communication
that is disrupted in ASD.23–25 Together, these data provide
strong statistical evidence for the involvement of com-
mon variation within CNTNAP2 in language acquisition
in autism and provide a framework to link this variation




Families analyzed in this study were selected from the AGRE re-
source.26 AGRE has human subjects’ approval and our use of the
AGRE repository was further approved by UCLA. The recruitment
and diagnostic protocol has been described previously,1,9,16,26 and
additional information is available on the AGRE website. Families
were excluded from the current study if a nonidiopathic autism
label (i.e., fragile-X, abnormal brain-imaging results, abnormal
karyotype) was recorded in a proband.26 The majority (79%) of the
samples are self-identiﬁed as white, while 7% identiﬁed them-
selves as being of a different race (i.e., black, Asian, Paciﬁc Islander,
etc.) or of mixed ancestry.
Assessment
TheAutismDiagnostic Interview (Revised) (ADI-R)27 is a semistruc-
tured interview, based on the ICD-10 and DSM-IV criteria for
autism diagnosis, given to the caregivers of individuals that may
be affected.27 For all subjects, a trained tester administered the
ADI-R in the family home per standard protocols.16,27 For the asso-
Figure 1. Dense SNP Analysis of the 7q35 Autism-Related
Language QTL Region Highlights Four Variants for Stage 2
Follow-Up
The negative log of the significance level of each block or single-
SNP transmission bias is plotted according to base-pair position.
Nominally significant SNPs (p < 0.01, pLOD > 2) that were
followed up in Stage 2 are boxed. Tics above the graph demarcate
gene content.The Aciation analysis, we analyzed a quantitative trait from the ADIR-R:
the age at which the subjects spoke their ﬁrst word (WORD).
The trait is familial and was used to identify the previously
reported QTL region on chromosome 7q35.1 Although WORD is
an amnestic language measure, it is signiﬁcantly negatively
correlated with the Peabody Picture Vocabulary Test Scores in
this sample, which is a contemporary measure of receptive
language.2
For Stage 1, data from 172 trios had the quantitative trait age at
ﬁrst word (WORD1,2) and were included in the quantitative asso-
ciation analysis. For Stage 2, an independent set of 304 parent-
child AGRE trios with the WORD phenotype were included in
the quantitative association analysis. In a typically developing
child, the ﬁrst word occurs before 12 months of age. In the Stage
1 sample, the average age at ﬁrst word in the offspring was 30.49
months (n ¼ 172; range ¼ 6 to 85 months). Although male off-
spring had an average WORD (mean ¼ 31.07; n ¼ 146; range ¼
6 to 85 months) that was slightly higher than that for female off-
spring (mean ¼ 27.23; n ¼ 26; range ¼ 8 to 60), this was not sig-
niﬁcantly different (p > 0.3). In Stage 2, the average WORD was
32.66 months (n ¼ 304, range ¼ 5 to 108 months). As in Stage
1, males (mean ¼ 33.3, n ¼ 243, range ¼ 5 to 108 months) and fe-
males (mean ¼ 30.15, n ¼ 61; range ¼ 7 to 84 months) were not
signiﬁcantly different (p ¼ 0.26) for WORD. The ratio of males
to females in this sample was 4.74 for Stage 1 and 3.98 for Stage
2, consistent with other reports of an increased prevalence of
the disorder in boys.5,10,28
Genotyping
For Stage 1, DNA samples obtained from cell lines housed at the
NIMH Cell Repository (Piscataway, NJ) were genotyped by Perle-
gen (Mountain View, CA). For Stage 2, samples were genotyped
either at the Southern California Genotyping Center (SCGC), an
on-site installation of the Illumina platform at UCLA (Illumina,
Inc., San Diego, CA29), or by Taqman assay completed in one of
our laboratories (D.H.G.) and scanned on an ABI7900 ﬂuores-
cent plate reader (Applied Biosystems, Foster City, CA). Details of
the Illumina genotyping platform have been discussed in detail
elsewhere.30–32
For Stage 1, based on information from samples previously gen-
otyped by Perlegen Sciences, 6242 SNPs with a call rate greater
than 80% and a minor allele frequency (MAF) greater than 10%
were identiﬁed across the linkage region. An adaptation of the
Lee-Kang algorithm33 was then used to identify a subset of 2892
SNPs that would cover the region with an average density of 1
SNP every 5.3 kb. From this, a total of 2758 SNPs across an esti-
mated 200 genes were successfully genotyped for Stage 1 at Perle-
gen Sciences by hybridization onto custom-designed Affymetrix
SNP arrays by methods similar to those described elsewhere17
(see Table S1 available online for marker details and descriptive sta-
tistics). All mapping and distance information is based on the Na-
tional Center for Biotechnology Institute Build 35 of the human
genome. The average heterozygosity of markers used in this study
was 35%, the minor allele frequency (MAF) was 27%, and the av-
erage call rate was 95%. The average number of Mendelian errors
over the whole sample was 0.002 (total number of errors/possible
errors). Individual markers were combined into 403 haplotype
blocks based on the four-gamete method34 (see below).
For Stage 2, blocks (n ¼ 3, covered by a total of six tagging SNPs)
and unlinked SNPs (n ¼ 2) identiﬁed in Stage 1 were genotyped
in 304 separate families. These eight SNPs within four genes,
KIAA1549, CNTNAP2, FLJ42291, and PRKAG2, were submittedmerican Journal of Human Genetics 82, 150–159, January 2008 151
Figure 2. Relative Location of Associated SNPs within CNTNAP2
Gene structure is depicted from 50 to 30 with exons represented by small blocks or lines along the gene, and the black arrowhead indicates
gene direction. The SNPs that comprised the nominally significant (p< 0.01) block 254 from Stage 1 are represented by blue vertical lines
over the bottom LD plot. The tag SNP, rs2710102, confirmed in the male-only trios (n ¼ 187) in Stage 2 is circled in red. The LD plot was
generated with the Haploview program.to Illumina for evaluation. SNPs with poor designability scores
(e.g., rs6965505 from FLJ42291) or missing calls were genotyped
in one of our laboratories (D.H.G.). As shown in Figure 2, the
four SNPs in CNTNAP2 block 254 identiﬁed in Stage 1 were in
high LD (r2 values for rs2710102 (tag), rs759178, rs1922892, and
rs2538991 ranged from .98 to 1); therefore, only rs2710102 was
typed in Stage 2.
QTL Region Coverage and Comparison to HapMap
The study presented herein was designed prior to the availability
of HapMap2.35 Although the HapMap does not provide complete
information, particularly with respect to rare alleles, it is the most
comprehensive catalog of human variation available over the ge-
nome and provides a clear standard by which to gauge coverage
of known variation over an interval of interest. Genotype data
from CEPH families were downloaded from the HapMap Project,
release #21, between 137480543 and 152996597 base pairs on
chromosome 7. Haploview (version 4.0RC1)36 was used to calcu-
late minor allele frequency (MAF), heterozygosity, and pair-wise
LD for SNPs separated by %100 kb. SNPs with MAF < 0.05 were
removed from analysis of HapMap data.
With those SNPs that were common to both our generated data
and those genotyped by the HapMap Project (n ¼ 1724) as tags,
62% of SNPs in HapMap (total number of HapMap SNPs in
region ¼ 11405) were covered by proxy at an average r2 ¼ 0.8.
Thus, the majority of variation captured by HapMap was assessed
by proxy in the current study. Because there were an additional
386 SNPs included in our generated data but not present in
HapMap, this is likely an underestimate of the actual variation
captured across the interval.152 The American Journal of Human Genetics 82, 150–159, JanuaryStatistical Analysis
Haploview36 was used to identify Mendelian errors, estimate allele
frequencies, test for Hardy-Weinberg equilibrium, estimate linkage
disequilibrium (LD) parameters, and identify haplotype blocks
with their respective tags (described below). From the 2758 origi-
nal markers typed, we excluded 648 SNPs that did notmeet at least
one of the following criteria: Hardy-Weinberg cutoff of 0.05, 90%
minimum genotype, maximum of 10 Mendelian errors, and a
MAF of 5%. Quality-control parameters for the 2758 SNPs are
reported in Table S1. LD was characterized by calculation of the
squared correlation coefﬁcient,37 r2, a conventional measure of as-
sociation equal to the square of the correlation coefﬁcient between
the alleles at two loci.38,39 This measure allows the prediction of
alleles at one SNP from the alleles at a second SNP.40 Although
markers were not removed from analysis in Stage 1 because of
high LD, it was considered in the selection of haplotype-block
tags, described below, which was performed with the Tagger
option in Haploview.
To provide sufﬁcient power to detect variants associated with
only modest effects, we used a standard two-stage design.41,42
Our haplotype-block strategy with independent samples limited
thenumberof tests conductedbygrouping relatedSNPsand testing
the set for association. In Stage 1, we deﬁned blocks in Haploview
by using the ‘‘four-gamete rule’’ option.34 This approach for haplo-
type block construction does not require subjective thresholds of
linkage disequilibrium measures or a minimum number of com-
mon haplotypes in a region; rather, recombination events are
identiﬁed and blocks are deﬁned as a set of nonrecombinant con-
tinuous SNPs.34 More speciﬁcally, in Haploview, the haplotypes
(i.e., gametes) and population frequencies for each pair of markers2008
are computed and a recombination event is considered to have
taken place when all four possible haplotypes have frequencies of
at least 0.01. Blocks are deﬁned by contiguous markers where
only three gametes exist.With this approach, 403blocks composed
of 1863 SNPs were obtained. An additional 257 SNPs were not
included in these blocks and were tested individually. The Tagger
function in Haploview was used to select tags for each of the 403
blocks,with an r2 thresholdof .85; thus, each selected tag had a cor-
relation of at least .85 with the SNPs it represented. All of the tags
covering the 403 blocks, as well as the 257 independent SNPs not
included in them,were subjected to a quantitative regression-based
association test with the Whole Haplotype Analysis Package
(WHAP) Software.WHAPuses a regressionanalysismethod for test-
ing SNP associationswith either qualitative or quantitative traits in
samples of unrelated individuals and/or parent-offspring trios. We
applied a conditionalmodel where the genotype is conditioned on
the quantitative trait and the mean and variance of the trait were
ﬁxed (10.32 and 6.05, respectively, estimated from 214 unaffected
children with typical language development). Evidence for associ-
ation with WORD was assessed by generating empiric p values by
permuting the genotypes within the trios 500 times in Stage 1
and 100,000 times in Stage 2.
Considering the possibility that heterogeneity at this language-
related QTL region could be due to proband sex, we divided the
Stage 2 sample into male-only and female-containing families




Recently, de novomicrodeletions or duplications have been impli-
cated in ASD etiology;11,12 therefore, we examined this trend in
our sample at our speciﬁc language locus by using representational
oligonucleotide microarray analysis (ROMA).
ROMAwas performed in 184 AGRE probands (including 38 pro-
bands from the association analysis) with genomic representa-
tions made with BglII as described previously,44 hybridized onto
85K arrays, which represent the genome at a density of an oligonu-
cleotide per average gene (every 50 kb on average45), followed by
390K arrays for validation (6–7 kb average spacing). Arrays were
manufactured per our speciﬁcations, and hybridizations were
performed in the NimbleGen Iceland facility, LindGen EHF.
Validation of ﬁndings from 85K ROMA scan was done with a
higher complexity representation called a ‘‘rubble-rep’’ and a
390K probe array (with an average spacing of one probe every
8 kb in the genome). A rubble-rep is performed by cleaving the ge-
nome with Dpn II and ligating the adaptors, then further deplet-
ing the Dpn II representation by cleavage with Alu I, followed
by ampliﬁcation.
Microarray Gene-Expression Analysis
Human brain material was obtained from the University of Mary-
land Brain and Tissue Bank under an approvedUCLA IRB protocol.
RNAwas extracted from left or right frontal lobes, superior tempo-
ral gyrus, or the remaining whole hemisphere (minus STG) from
eight human fetal brains, gestational age 17–22weeks (two female,
ﬁvemale, oneunknown). RNAqualitywas assessedvia spectropho-
tometry with the nanodrop spectrophotometer (A260/280 > 1.8)
and Agilent Bio-Analyzer (28 s:18 s > 2). Labeling, hybridization,
and scanning were then carried out as per manufacturer’s instruc-
tions. Single-channel Affymetrix expression values were calculatedThe Aand arrays normalized with the RMA package in R.46 dChip47 was
thenused to identifygenes that showed fold-change>1.3, absolute
difference between means > 100, and p < 0.01. For two-color Agi-
lent arrays, differential expression (DE) was said to occur when
genes showed at least a 1.53 difference between groups, had an
average signal 23 background, and p < 0.01 after correction for
multiple comparisons with the software package Limma.48
In Situ Hybridization
Additional human brains obtained as above from the University of
Maryland Brain and Tissue Bank under an approved UCLA IRB
protocol were used for in situ hybridizations. Experiments were
performed with CNTNAP2 gene-speciﬁc probes applying previ-
ously published methods.49 All hybridizations were performed
on sections from multiple additional brains (ﬁve female, one un-
known) with two distinct CNTNAP2-speciﬁc riboprobes, one con-
sisting of a large 4 kb fragment spanning 50UTR, coding region,
and 30UTR (bps 550–4300 of NM_014141; pBSA2) and a second
600 bp probe corresponding to the 30 end of the protein-coding re-
gion (bps 3550–4100 of NM_014141; pBSA13). Results with each
of the two probes were indistinguishable. Sense control showed
no signal (data not shown).
Results
Stage 1: Association Analysis of the 7q35 Region
In Stage 1, 2758 single-nucleotide polymorphisms with an
average intermarker distance of 5.6 kb were genotyped in
172 parent/child trios from the AutismGenetic Resource Ex-
change (AGRE). Quantitative single- or multimarker family-
based association analyses were performed with the age
at ﬁrst word (WORD) trait, which is familial and used
previously to identify the 7q35 language QTL region in
multiplex autism families.1
To avoid premature exclusion of genes in the ﬁrst com-
prehensive assessment of this region, we took a liberal ap-
proach in the initial screen and used a signiﬁcance thresh-
old of p < 0.01 to select blocks and independent SNPs for
Stage 2 follow-up (refer to Figure 1). Four Stage 1 genes,
KIAA1549, CNTNAP2, PRKAG2, and FLJ42291, were tested
in Stage 2.
Stage 2: Independent Sample Analysis
Implicates CNTNAP2
The ﬁrst stage association analysis of 172 trios narrowed the
number of genes for the second stage investigation fromap-
proximately 200 to 4: KIAA1549, CNTNAP2, PRKAG2, and
FLJ42291, each of which was represented by blocks and/or
independent SNPs. Several independent lines of evidence
made CNTNAP2, a Neurexin family member, a strong a pri-
ori candidate. First, mutations in Neuroligin genes, known
to interact with b-Neurexins, have been identiﬁed in
ASD.20,21 Second, the disruption of CNTNAP2 in a family
segregating severe intellectual disability and repetitive
behaviors has been reported.50 Third and most recently,
mutations in CNTNAP2 itself segregate with a recessive
seizure disorder associated with ASD and language delay.22
Of the variants characterized in Stage 2, only that withinmerican Journal of Human Genetics 82, 150–159, January 2008 153
CNTNAP2 (block 254, tagged by rs2710102; Figure 2)
showed any relationship to WORD (p ¼ 0.028; Table 1).
Because of the overrepresentation of males in samples
with ASD and those with language delay,51 as well as ev-
idence for sex-speciﬁc effects on 7q,52 we hypothesized
that stratifying by sex may reduce genetic heterogeneity
at this locus. The association between rs2710102 and
WORD appeared to be driven by the male-only trios
(p ¼ 0.005; Table 1). However, to provide an empirical
estimate of signiﬁcance for the sex stratiﬁcation, we fol-
lowed the previously described procedure to assess
empiric signiﬁcance by permutation43 and randomly
selected samples of 187 trios from the Stage 2 data set
and ran the association analysis; we repeated this pro-
cedure 500 times. Only 11 of the total 500 trials had a
signiﬁcance value less than 0.005 (from Table 1); thus,
the empiric p value for the male-only association was
<0.02. These results demonstrated that sex was an impor-
tant factor in the association between CNTNAP2 and
WORD.
Microdeletion Identiﬁed by ROMA
By using ROMA, we identiﬁed a microdeletion within
CNTNAP2 shown in Figure 3. This variant was present
in a proband and his father, but not in the proband’s
affected sibling or in 1000 control chromosomes screened
separately.
Table 1. Association Results for a Block-Based Analysis of
the 7q35–36 Language QTL Region





KIAA1549 9 rs896193 137975311 0.004 0.12 0.29 0.34
9 rs10435435 137977766
9 rs6467813 137989463
CNTNAP2 254 rs2710102 146966131 0.002 0.028 0.005d 0.87
PRKAG2 355 rs2302532 150699953 0.008 0.17 0.033 0.66
355 rs7788234 150706305
PRKAG2 rs17173197 150706568 0.01 0.51 0.25 0.56
FLJ42291 rs6965505 152537834 0.002 0.77 0.30 0.42
Blocks and independent SNPs were identified in Stage 1 (p < 0.01) and
tested in an independent sample in Stage 2 by age at first word.
a p values for blocks were obtained by running the corresponding tags as a
group in Whap. p values for independent SNPs (rs17173197, rs6965505)
were obtained by running each marker individually. Only results with
p values less than 0.01 in Stage 1 (shown here) were tested in Stage 2.
b Empirical p values for Stage 1 were obtained in Whap with 500 permuta-
tions. Stage 1 included 172 trios.
c Empirical p values for Stage 2 were obtained in Whap with 100,000
permutations. Stage 2 included 304 trios: 187 male-only trios and 117
female-containing trios.
d The significance of stratifying the sample by sex was estimated empiri-
cally by choosing 500 sets of 187 families at random; the association anal-
ysis was then performed on each of these sets. The empirical p value for the
male-specific effect was <0.02.154 The American Journal of Human Genetics 82, 150–159, JanuaryCNTNAP2 Expression during Fetal
Brain Development
In an independent line of investigation, we performed ge-
nome-wide microarray studies of regional gene expression
in eight human fetal brains to identify genes enriched in
human language-related association cortex.53 Standard
genome-wide false discovery thresholds in each of two sep-
arate microarray platforms identiﬁed a common set of 12
genes differentially expressed between superior temporal
gyrus and the remaining cerebral hemisphere (hypergeo-
metric probability of overlap; p< 3.33 1013). One of these
differentially expressed genes was CNTNAP2 (Table 2).
CNTNAP2 expression was further investigated by in situ
hybridization to provide independent conﬁrmation of the
array data in additional brains and also give a detailed as-
sessment of regional distribution. These experiments re-
vealed that CNTNAP2 was highly restricted to frontal and
anterior temporal lobes, striatum, and dorsal thalamus
(Figure 4). This unusually restricted pattern of expression
for CNTNAP2 recapitulates the well-established cortico-
striato-thalamic circuitry known to modulate human cog-
nitive function. These results are striking given that these
heavily interconnected structures are known to contribute
to complex human behaviors including speech and lan-
guage,54 reward, frontal executive function,55 as well as
joint attention, a core deﬁcit in ASD.56,57
Discussion
This studyprovides evidence in support of commongenetic
variation inCNTNAP2modulating language onset inmales
and underlying ASD susceptibility. Our two-stage analysis
identiﬁed an association between variation at rs2710102
and age at ﬁrst word in ASD samples from male-only fami-
lies. These SNP association results do not imply that varia-
tion at rs2710102 is causally related to ASD but rather that
variation here is likely to be in linkage disequilibrium
with an as yet untested, functional variant. Identifying
the underlying causal variant(s) inCNTNAP2will be highly
informative although this is also likely to be complicated
given the absence of nearby polymorphisms within the
coding region and the size of the genic region.
It is of particular interest that the association between
rs2710102 and age at ﬁrst word appeared to be most pro-
nounced among affected males. Despite the absence of sig-
niﬁcant differences in WORD between affected males and
females,1,2 the increased prevalence of ASD in males com-
pared to females5,10,28 along with the preponderance of
males in language-delayed samples,51 made it reasonable
to expect that the underlying genetic modulators for ASD
may differ as a function of sex. In support of this notion,
results from an independent qualitative linkage study
show that a separate linkage peak on chromosome 7q
was largely due to male-male affected sibpairs.43,52
The association between rs2710102 in CNTNAP2
with age at ﬁrst word, coupled with its well-deﬁned2008
Figure 3. Representational Oligonucleotide Microarray Analysis and Assessment of Mendelian Errors in SNPs Identify a Rare
CNTNAP2 Deletion
The two vertical lines in the graph show the endpoints of the deletion estimated from ROMA data by a Hidden Markov Model-based pre-
dictor. SNP genotyping data are superimposed on the graph at the bottom. The two green triangles represent SNPs that were informative
and showed no Mendelian errors, indicating that the deleted region is somewhere between these two points. Purple diamonds denote
SNPs that showed Mendelian errors consistent with a deletion. Orange squares represent SNPs that were uninformative. Chromosome
7 locations are from the UCSC Genome Browser May 2004 assembly.developmental expression, are especially interesting in
light of two independent lines of supporting evidence.
The ﬁrst is the recent identiﬁcation of a rare recessive mu-
tation in CNTNAP2 that segregates with seizures, develop-
mental language delay, and autism in an extended Amish
kindred.22 All patients had seizures with onset between
14 and 20 months of age, and these were followed by the
abrupt decline of learning ability and social skills, as well
as language regression and aberrant social behavior, and
nearly 2/3 were diagnosed with PDD-NOS, an autism spec-
trum condition. It is notable that pathological examina-
tion of resected tissue from several of the reported Amish
cases revealed widespread abnormalities of neuronal mi-
gration including the anterior temporal lobe and amyg-
dala, whereas imaging data revealed abnormalities in theThe Afrontal and temporal lobes, as well as basal ganglia. Seizure
foci were most pronounced in the anterior temporal and
frontal lobes, a pattern that is explained by the focal ex-
pression pattern of CNTNAP2 during fetal brain develop-
ment shown here. It is well established that a signiﬁcant
proportion of patients with autism suffer from seizures,58
typically arising well after the age of ﬁrst diagnosis. These
observations suggest that the common CNTNAP2 risk al-
lele identiﬁed here contributes to ASD and related condi-
tions, concomitantly increasing the risk for language delay,
most likely as a consequence of the disruption of a critical
neurodevelopment process, such as neuronal migration,
and may cause cortical dysplasia that carries the potential
for wide-ranging phenotypic effects, including seizures,
regression, and ASD.Table 2. Microarray Expression for CNTNAP2 in Superior Temporal Gyrus versus the Rest of the Cerebral Hemisphere
Probe Platform STG Mean HEM Mean Fold Change Difference of Means t p
A_23_P84399 Agilent 2727.50 6457.50 2.37 3730 12.80 .003
219301_s_at Affymetrix 140.30 242.84 1.73 103 4.53 .0005
STG, superior temporal gyrus; HEM, cerebral hemisphere.merican Journal of Human Genetics 82, 150–159, January 2008 155
The second alternative line of supporting evidence for
the involvement of CNTNAP2 in ASD etiology consists of
the ﬁndings described in two separate studies appearing
in this issue of AJHG.59,60 Arking and colleagues performed
linkage and association whole-genome scans by using the
qualitative diagnosis of autism in a total of 72 multiplex
families from the AGRE cohort; 34 and 36 of which were
in Stages 1 and 2, respectively, of the present study. With
a stringent qualitative diagnosis of autism, a genome-wide
signiﬁcant linkage signal was detected in the 7q35 region;
subsequently, they identiﬁed and conﬁrmed an associated
variant at the 50 end of CNTNAP2.59 Although our previous
linkage reports1,2 aswell as thework byArking et al. support
the potential involvement of multiple genes in the 7q35
region, it remains striking that, in the end, themost impor-
tant ﬁndings from the two independent laboratories
converged on common variants from only one gene. Inter-
estingly, Bakkaloglu and colleagues provide support for the
involvement of rare CNTNAP2 variants with ASD.60 Based
on the identiﬁcationof a chromosomal break that disrupted
CNTNAP2 in a patient with autistic disorder, the authors
sequenced a large cohort of patients (10 of which were in-
cluded in the present report) and controls; they found sev-
eral likely functional rare variants in patients with autism
that were not present in controls. Although there is a mod-
est sample overlap among these three studies (described in
detail59 and see Figure S1), the results remained consistent
when these families were excluded (data not shown).
Thus, together, these original studies provide evidence
that both rare and commonvariants inCNTNAP2may con-
tribute to the development of ASD and its behavioral endo-
phenotypes. In the future as more data are gathered, it will
be important to relate speciﬁc forms of variation, rare and
common, to speciﬁc aspects of the phenotype in patients,
ranging from language and social function to brain struc-
ture and epilepsy.
Because it is increasingly apparent that de novomicrode-
letions or duplications can be important in ASD etiol-
ogy,11,12 we examined this phenomenon in our sample at
our speciﬁc language locus. By using ROMA, we identiﬁed
a microdeletion within CNTNAP2 (Figure 3). This variant
was present in a proband and his father, but not in 1000
control chromosomes screened separately. Although this
large intronic deletion was not observed in the other autis-
tic sibling of the index family (AU0383), it is reasonable
that regulatory elements within the deleted region may
impact gene function. In a recent 10K SNP genome scan,
similar transmissions were observed for large deletions in
other regions highly likely to be critical.61 Thus, the lack
of segregation of this deleted variant with ASD suggested
that this observation may either be spurious or contribute
to ASD via complex mechanisms. More broadly, these data
support the notion that large CNVs at the CNTNAP2 locus
are not a common cause of autism or a major contributor
to the language QTL studied here. As is currently the case
for most complex genetic diseases, the ﬁeld is in the early
phases of study, and thus the overall allelic architecture
of ASD remains to be determined: speciﬁcally, how much
of its overall genetic risk will be explained by common
versus rare variants.
The broad chromosome 7q2–35 region is the only region
linked to ASD at genome-wide signiﬁcance in ameta-analy-
sis of ASD genome scans, and it has reached nominal signif-
icance levels in nearly all of the individual genome scans
performed to date.62,63 Given the extensive heterogeneity
of genetically complex diseases such as ASD, it is reasonable
to assume that the identiﬁcation of relatively strong and re-
producible linkage peaks may reﬂect the presence of multi-
ple susceptibility genes within that region.64 It is important
to note that other studies have provided evidence for link-
age to the qualitative phenotype of ASD at more proximal
regions on chromosome 7q2–34. These and other data,
Figure 4. CNTNAP2 Expression in Hu-
man Fetal Brain Demarcates Anterior
Frontal and Temporal Perisylvian
Regions, Striatum, and Thalamus
(A) Autoradiograms of midline sagittal
sections obtained from an 18-week and a
20-week fetal brain show striking enrich-
ment of CNTNAP2 in frontal gray matter,
corresponding roughly to a region between
the orbital gyrus and superior frontal cor-
tical anlagen. Strong labeling is also ob-
served in basal ganglia, thalamus, and
amygdala.
(B) Autoradiograms of coronal sections
from two 19-week fetal brains demonstrate
high levels of CNTNAP2 in amygdala, cau-
date, cortical plate, dorsal thalamus, and
putamen. Abbreviations: Amyg, amygdala;
Caud, caudate; Ctx, cortex; Put, putamen;
and Thal, thalamus.156 The American Journal of Human Genetics 82, 150–159, January 2008
together with our own report, support the possibility that
additional ASD-susceptibility genes may lie on chromo-
some 7q and in other regions, such as chromosome 3q
with evidence for linkage to language delay in ASD.2,52
Here we present evidence for the contribution of varia-
tion within CNTNAP2 to variability in age at ﬁrst word in
males. Moreover, our demonstration of the developmental
expression of CNTNAP2 being conﬁned to brain circuitry
known to be disrupted in ASD23,25 provides, to our knowl-
edge for the ﬁrst time, a link between genetic risk for
language dysfunction in autism and speciﬁc brain regions
known to underlie core processes impaired in this disorder.
Supplemental Data
One table and one ﬁgure can be found with this article online at
http://www.ajhg.org/cgi/content/full/82/1/150/DC1/.
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